Medtronic launching Atakr radiofrequency ablation system following FDA approval.
This article was originally published in The Gray Sheet
Executive Summary
MEDTRONIC ATAKR RF ABLATION SYSTEM SALES TO BEGIN IMMEDIATELY following FDA's Feb. 13 approval of a premarket application for the device. The Atakr is the second radiofrequency catheter ablation system approved by FDA for commercial release; EP Technologies' RF Cardiac Ablation System was approved in October.